Need help choosing the right code?
Ask CasePilot about procedures, modifiers, bundling, and coding guidance.
Try CasePilot© Copyright 2026 American Medical Association. All rights reserved.
The CPT® Code 80367 refers to a laboratory test specifically designed to measure the presence of propoxyphene, also known as dextropropoxyphene, in various biological samples such as meconium stool, urine, serum, or plasma. Propoxyphene is classified as an analgesic and antitussive medication, which was commonly used in combination with other pain relievers like aspirin or acetaminophen. It was marketed under brand names such as Darvon and Darvocet. However, it is important to note that propoxyphene has been removed from the market in the United States since November 2010 due to serious safety concerns, including the risk of fatal overdoses and cardiac arrhythmias associated with its use. The testing process involves obtaining a blood sample through a procedure known as venipuncture, which is separately reportable. For urine samples, collection can be done via random voiding or catheterization, while meconium stool is typically collected from a diaper. The analysis of these samples is conducted using advanced techniques such as quantitative high performance liquid chromatography-tandem mass spectrometry, which allows for precise measurement of the drug levels in the collected specimens.
© Copyright 2026 Coding Ahead. All rights reserved.
The laboratory test coded as CPT® 80367 is indicated for the detection and quantification of propoxyphene in various biological samples. The specific indications for performing this test include:
The procedure for conducting the test associated with CPT® 80367 involves several key steps, which are detailed as follows:
After the completion of the testing procedure for CPT® 80367, the samples are analyzed, and results are generated. The expected post-procedure care primarily involves the interpretation of the test results by qualified healthcare professionals. It is crucial to ensure that the results are communicated effectively to the relevant parties, such as the prescribing physician or the patient, as appropriate. Additionally, any necessary follow-up actions based on the test results should be determined, which may include further clinical evaluation or intervention if propoxyphene levels are found to be elevated or indicative of misuse. Proper documentation of the test results and any subsequent actions taken is also essential for compliance and continuity of care.
| Short Descr | DRUG SCREENING PROPOXYPHENE | Medium Descr | DRUG SCREENING PROPOXYPHENE | Long Descr | Propoxyphene | Status Code | Not Valid for Medicare Purposes | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 9 - Not Applicable | Multiple Procedures (51) | 9 - Concept does not apply. | Bilateral Surgery (50) | 9 - Concept does not apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 9 - Concept does not apply. | Co-Surgeons (62) | 9 - Concept does not apply. | Team Surgery (66) | 9 - Concept does not apply. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | APC Status Indicator | Code Not Recognized by OPPS when submitted on Outpatient Hospital Part B Bill Type (12x/13x) | Type of Service (TOS) | 5 - Diagnostic Laboratory | Berenson-Eggers TOS (BETOS) | T2D - Other tests - other | MUE | 1 |
| 90 | Reference (outside) laboratory: when laboratory procedures are performed by a party other than the treating or reporting physician or other qualified health care professional, the procedure may be identified by adding modifier 90 to the usual procedure number. | GZ | Item or service expected to be denied as not reasonable and necessary |
|
Date
|
Action
|
Notes
|
|---|---|---|
| 2015-01-01 | Added | Added |
Get instant expert-level medical coding assistance.